IDHC Integrated Diagnostics Holdings plc

0.4620USD0.00%Mkt Cap: 268.57M USDP/E: 9.24

Integrated Diagnostics Holdings plc, a consumer healthcare company, provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematolo…

Institutional holders1 on file

Key Statistics

Company
Market Cap268.57M USD
Enterprise Value—
Revenue (TTM)—
Gross Profit3.35B EGP
Net Income (TTM)1.26B EGP
Revenue/Share—
Last Price0.4620 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees7.1K
CountryGB
SectorHealthcare
IndustryDiagnostics & Research
ISINJE00BLKGSR75
Valuation
P/E (Trailing)9.24
P/E (Forward)0.26
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.09
EPS (TTM)0.05 EGP
EPS (Forward)1.77 EGP
52W Range
0.44504% of range0.8350
52W High0.8350 USD
52W Low0.4450 USD
Profitability
Gross Margin42.69%
Oper. Margin0.00%
EBITDA Margin31.92%
Profit Margin16.07%
ROE37.31%
ROA14.69%
ROIC36.07%
ROCE36.02%
Growth
Revenue Growth42.00%
Earnings Growth25.50%
Cash Flow & Leverage
Operating CF1.90B EGP
CapEx (TTM)521.04M EGP
FCF Margin—
FCF Yield—
Net Debt—
Net Debt/EBITDA—
Net Debt/FCF—
Balance Sheet
Debt/Equity0.48
Current Ratio1.67
Quick Ratio1.35
Book Value/Sh5.37 EGP
Cash/Share—
Dividends
Fwd Div Rate0.01 USD
Trail. Div Rate0.00 USD
Div. Yield1.84%
5Y Avg Yield5.70%
Payout Ratio48.11%
Ex-Div DateMay 28, 2026
Pay Date—
Splits
Last Split4:1
Split DateDec 24, 2020
Analyst Consensus
Rating1.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)0.9384 USD
Upside (mean)+103.1%
Target Range0.7855 USD – 1.091 USD
0.7855+103.1% to mean1.091
# Analysts2
Ownership
Shares Out.581.33M
Float124.82M
Insiders61.41%
Institutions45.04%
Technical
SMA 500.5066 (-8.8%)
SMA 2000.5544 (-16.7%)
Beta0.47
S&P 52W Chg12.08%
Avg Vol (30d)1.09M
Avg Vol (10d)26.00K
Technical Indicators
RSI (14)42.9
MACD-0.0094
MACD Signal-0.0106
MACD Hist.+0.0012
BB Upper0.4959 USD
BB Middle0.4698 USD
BB Lower0.4437 USD
BB Width11.13%
ATR (14)0.0280 USD
Vol Ratio (20d)0.08x

About Integrated Diagnostics Holdings (LON: IDHC)

›

Integrated Diagnostics Holdings (LON: IDHC) is listed on the London Stock Exchange, where its shares trade in USD. It belongs to the Diagnostics & Research industry, part of the Healthcare sector, and reports about 7,137 employees.

The shares were at 0.4620 USD on 19 November 2026, down 30.5% over 52 weeks. Its 52-week range is 0.4450 USD to 0.8350 USD: the price is 44.7% below the high and 3.8% above the low.

At a market capitalisation of 268.57M USD, it trades at 9.2 times trailing earnings. The median trailing P/E of its 18 largest Diagnostics & Research peers is 35.8, a discount of 74% for IDHC. It pays a dividend yielding 1.84% (it pays out 48% of its earnings), against a median of 0.73% among the dividend payers in that peer group.

Integrated Diagnostics Holdings reports return on equity of 37.3%, an operating margin of 0.0% and revenue up 42.0% year over year.

Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. 2 analysts cover the stock, with an average rating of Buy; their mean price target of 0.9384 USD is 103.1% above the current price.